Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Earnings Preview: Accolade

Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Monday, 2022-01-10. Here's what investors need to know before the announcement. Analysts estimate that Accolade will likely report an Earnings Per Share (EPS) of $-0.74.

ACCD

Read More

Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Dec. 13, 2021: SYSS, NTLA, DNA, PD, BLI, CRSP, MTLS, NVTA, VUZI, BLDE, ROKU, COIN, EDR, ONEM, SDGR, ACCD, SLGC, MASS, QSI, PSNL, PATH, TOST, HOOD, SE, NU, KTOS, AVAV

STRATASYS LTD (SSYS) - 78600 INTELLIA THERAPEUTICS INC (NTLA) - 16800 GINKGO BIOWORKS HOLDINGS INC (DNA) - 130745 PAGERDUTY INC (PD) - 24394 BERKELEY LIGHTS INC (BLI) - 29549 CRISPR THERAPEUTICS AG (CRSP) -

ACCD